| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.049 | 0.3 |